1. Home
  2. ASRT vs CODA Comparison

ASRT vs CODA Comparison

Compare ASRT & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASRT
  • CODA
  • Stock Information
  • Founded
  • ASRT 1995
  • CODA 1994
  • Country
  • ASRT United States
  • CODA United States
  • Employees
  • ASRT N/A
  • CODA N/A
  • Industry
  • ASRT Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • ASRT Health Care
  • CODA Industrials
  • Exchange
  • ASRT Nasdaq
  • CODA Nasdaq
  • Market Cap
  • ASRT 57.9M
  • CODA 88.7M
  • IPO Year
  • ASRT 1997
  • CODA N/A
  • Fundamental
  • Price
  • ASRT $0.66
  • CODA $8.49
  • Analyst Decision
  • ASRT Strong Buy
  • CODA Strong Buy
  • Analyst Count
  • ASRT 2
  • CODA 1
  • Target Price
  • ASRT $3.25
  • CODA $11.00
  • AVG Volume (30 Days)
  • ASRT 239.8K
  • CODA 49.8K
  • Earning Date
  • ASRT 08-06-2025
  • CODA 06-16-2025
  • Dividend Yield
  • ASRT N/A
  • CODA N/A
  • EPS Growth
  • ASRT N/A
  • CODA 21.86
  • EPS
  • ASRT N/A
  • CODA 0.30
  • Revenue
  • ASRT $119,001,000.00
  • CODA $22,758,966.00
  • Revenue This Year
  • ASRT N/A
  • CODA $30.82
  • Revenue Next Year
  • ASRT $11.91
  • CODA $20.84
  • P/E Ratio
  • ASRT N/A
  • CODA $28.49
  • Revenue Growth
  • ASRT N/A
  • CODA 24.78
  • 52 Week Low
  • ASRT $0.51
  • CODA $5.76
  • 52 Week High
  • ASRT $1.80
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • ASRT 49.02
  • CODA 61.02
  • Support Level
  • ASRT $0.63
  • CODA $7.86
  • Resistance Level
  • ASRT $0.73
  • CODA $8.50
  • Average True Range (ATR)
  • ASRT 0.03
  • CODA 0.35
  • MACD
  • ASRT 0.00
  • CODA -0.01
  • Stochastic Oscillator
  • ASRT 36.64
  • CODA 75.39

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

Share on Social Networks: